Inflation, Real-Estate Numbers Featured in Short Week U.S. Monday Featured Earnings Goldman Sachs Group, Inc. (NYS ...

A April filing shows that Representative Josh Gottheimer reported a sale in Abbott Laboratories ABT, valued between $32,032 and $480,000. The transaction date is listed as April 10, 2025, with the ...

Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

Medtech trade group AdvaMed sounded positive today about President Donald Trump's decision to pause some tariffs for 90 days.

To get a sense of who is truly in control of Abbott Laboratories (NYSE:ABT), it is important to understand the ownership structure of the business. With 79% stake, institutions possess the maximum ...

A leader in Abbott's Heart Failure division announced that the company named Dr. Finn Gustafsson as the unit's chief medical ...

We recently published a list of the 8 Most Profitable Dividend Stocks to Buy Now. In this article, we are going to take a ...

“A study of past stagflation-like period shows that it is a headwind for equities, but dividend strategies tend to be more ...

The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by AI stocks. The ...